115
Views
446
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells

, , , , , , & show all
Pages 3436-3444 | Received 15 Nov 2000, Accepted 13 Feb 2001, Published online: 28 Mar 2023

REFERENCES

  • Brown, J. M., and A. J. Giaccia. 1998. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58:1408–1416.
  • Carmeliet, P., Y. Dor, J. M. Herbert, D. Fukumura, K. Brusselmans, M. Dewerchin, M. Neeman, F. Bono, R. Abramovitch, P. Maxwell, C. J. Koch, P. Ratcliffe, L. Moons, R. K. Jain, D. Collen, and E. Keshet. 1998. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485–490.
  • Ebert, B. L., and H. F. Bunn. 1999. Regulation of the erythropoietin gene. Blood 94:1864–1877.
  • Fell, D.. 1997. Understanding the control of metabolism. Portland Press/Ashgate Publishing Co., Brookfield, Vt.
  • Firth, J. D., B. L. Ebert, C. W. Pugh, and P. J. Ratcliffe. 1994. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Nat. Acad. Sci. USA 91:6496–6500.
  • Firth, J. D., B. L. Ebert, and P. J. Ratcliffe. 1995. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270:21021–21027.
  • Gillies, R. J., P. A. Schornack, T. W. Secomb, and N. Raghunand. 1999. Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1:197–207.
  • Hamilton, E., M. Fennell, and D. M. Stafford. 1995. Modification of tumour glucose metabolism for therapeutic benefit. Acta Oncologica 34:429–433.
  • Huang, L. E., J. Gu, M. Schau, and H. F. Bunn. 1998. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Nat. Acad. Sci. USA. 95:7987–7992.
  • Iyer, N. V., L. E. Kotch, F. Agani, S. W. Leung, E. Laughner, R. H. Wenger, M. Gassmann, J. D. Gearhart, A. M. Lawler, A. Y. Yu, and G. L. Semenza. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12:149–162.
  • Johnson, R., B. Spiegelman, D. Hanahan, and R. Wisdom. 1996. Cellular transformation and malignancy induced by ras require c-Jun. Mol. Cell. Biol. 16:4504–4511.
  • Lehninger, A. L., M. M. Cox, and D. L. Nelson. 1993. Principles of biochemistry, 2nd ed. Worth Publishers, New York, N.Y
  • Maxwell, P. H., G. U. Dachs, J. M. Gleadle, L. G. Nicholls, A. L. Harris, I. J. Stratford, O. Hankinson, C. W. Pugh, and P. J. Ratcliffe. 1997. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94:8104–8109.
  • O'Rourke, J. F., C. W. Pugh, S. M. Bartlett, and P. J. Ratcliffe. 1996. Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. Eur. J. Biochem. 241:403–410.
  • Rodrı́guez-Enrı́quez, S., and R. Moreno-Sánchez. 1998. Intermediary metabolism of fast-growth tumor cells. Arch. Med. Res. 29:1–12.
  • Ryan, H., J. Lo, and R. S. Johnson. 1998. The hypoxia inducible factor-1 alpha gene is required for embryogenesis and solid tumor formation. EMBO J. 17:3005–3015.
  • Ryan, H. E., M. Poloni, W. McNulty, D. Elson, M. Gassmann, J. M. Arbeit, and R. S. Johnson. 2000. Hypoxia-inducible factor-1 alpha is a positive factor in solid tumor growth. Cancer Res. 60:4010–4015.
  • Salceda, S., and J. Caro. 1997. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272:22642–22647.
  • Sauer, B., and N. Henderson. 1990. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol. 2:441–449.
  • Schmaltz, C., P. H. Hardenbergh, A. Wells, and D. E. Fisher. 1998. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18:2845–2854.
  • Semenza, G. L.. 1998. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J. Lab. Clin. Med. 131:207–214.
  • Stryer, L.. 1995. Biochemistry, 4th ed. W. H. Freeman, New York, N.Y
  • Wang, G. L., and G. L. Semenza. 1993. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268:21513–21518.
  • Wang, G. L., and G. L. Semenza. 1993. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90:4304–4308.
  • Wang, G. L., and G. L. Semenza. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1230–1237.
  • Warburg, O. H.. 1947. Ideen zur Fermentchemic der Tumoren. Akademie-Verlag, Berlin, Germany
  • Zelzer, E., Y. Levy, C. Kahana, B. Z. Shilo, M. Rubinstein, and B. Cohen. 1998. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J. 17:5085–5094.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.